[EN] COMPOUNDS FOR TREATMENT OF CARDIAC ARRHYTHMIAS AND HEART FAILURE<br/>[FR] COMPOSÉS POUR LE TRAITEMENT D'ARYTHMIES CARDIAQUES ET DE L'INSUFFISANCE CARDIAQUE
申请人:ELEX BIOTECH INC
公开号:WO2019191502A1
公开(公告)日:2019-10-03
This disclosure concerns compounds and a method for modulating the activity of calcium ion channels, including Ca2+-induced (or Ca2+-activated) calcium release channels and conformationally coupled calcium release channels such as ryanodine receptors. Some of the compounds have a structure according to formula I, or a stereoisomer, tautomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof.